Medicare Enrolled

Dr. Guillermo Philipps, M.D.

Neurology with Special Qualifications in Child Neurology Physician · Port Charlotte, FL
Low-engagement
22655 BAYSHORE RD STE 110, Port Charlotte, FL 33980
9412354900
In practice since 2009 (17 years)
NPI: 1992943781 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Philipps from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Philipps? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Philipps

Dr. Guillermo Philipps is a neurology with special qualifications in child neurology physician in Port Charlotte, FL, with 17 years of NPI registration.

Between the years covered by Open Payments, Dr. Philipps received a total of $3,693 from 32 pharmaceutical and/or device companies across 88 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology with special qualifications in child neurology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Philipps is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice $3,693 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$3,693
Total received (2018-2024)
Avg $528/year across 7 years
Top 39% in FL for neurology with special qualifications in child neurology physician
32
Companies
88
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,773 (75.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$720 (19.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$200 (5.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$225
2023
$484
2022
$875
2021
$32
2020
$208
2019
$935
2018
$933

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
PTC Therapeutics, Inc.
$720
LivaNova USA, Inc.
$350
Sunovion Pharmaceuticals Inc.
$331
UCB, Inc.
$239
SK Life Science, Inc.
$219
ACADIA Pharmaceuticals Inc
$200
Novartis Pharmaceuticals Corporation
$147
Supernus Pharmaceuticals, Inc.
$143
Biogen, Inc.
$127
Eisai Inc.
$125
Sumitomo Pharma America, Inc.
$123
Genentech USA, Inc.
$123
AveXis
$103
Novartis Gene Therapies, Inc. (fka AveXis, Inc.)
$88
BioMarin Pharmaceutical Inc.
$84
Ironshore Pharmaceuticals Inc.
$78
Tris Pharma Inc
$66
Shire North American Group Inc
$59
Mallinckrodt LLC
$57
JAZZ PHARMACEUTICALS INC.
$43
Lundbeck LLC
$42
AQUESTIVE THERAPEUTICS, INC.
$31
Corium, LLC
$26
NOBELPHARMA AMERICA, LLC
$25
Neos Therapeutics, LP
$25
EISAI INC.
$23
GENZYME CORPORATION
$21
Sarepta Therapeutics, Inc.
$18
Zogenix Inc.
$17
Saol Therapeutics Inc.
$14
Retrophin, Inc.
$14
Mallinckrodt Enterprises LLC
$12
Top 3 companies account for 37.9% of total payments
Associated products mentioned in payments ›
ACTHAR · AFINITOR · APTIOM · AZSTARYS · Adzenys XR-ODT · Briviact · DAYBUE · Dyanavel XR · EMFLAZA · EPIDIOLEX · EXONDYS 51 · Evrysdi · Fintepla · Fycompa · HYFTOR · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · LATUDA · LUMIZYME · Lioresal (baclofen) · ONFI · OXTELLAR XR · QELBREE · Quillivant XR · SPINRAZA · SYMPAZAN · VNS Therapy · VYVANSE · Vimizim · Vimpat · XCOPRI · XYREM · ZOLGENSMA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (75%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurology with special qualifications in child neurology physician in Port Charlotte?
Compare neurology with special qualifications in child neurology physicians in the Port Charlotte area by procedure volume, costs, and industry payment transparency.
Browse neurology with special qualifications in child neurology physicians nearby

Geographic Context

Neurology with special qualifications in child neurology physicians within 10 mi
4
Per 100K population
2.1
County median income
$66,154
Nearest hospital
Adventhealth Port Charlotte
2.9 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Philipps is a neurology with special qualifications in child neurology physician, with low-engagement industry engagement, with 17 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Philipps receive payments from pharmaceutical companies?
Yes. Dr. Philipps received a total of $3,693 from 32 companies across 88 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Philipps) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →